Search results
Author(s):
Gurleen Kaur
,
Swati Chand
,
Devesh Rai
,
et al
Added:
1 year ago
Author(s):
David Morrow
Added:
3 years ago
Risk stratification of patients with an acute coronary syndrome (ACS) starts on presentation and is a continuous process to predict those who are at high risk for further ischemic events or adverse outcomes. Among patients with non-ST-elevation myocardial infarction (NSTEMI), risk stratification begins with initial assessment to detect patients at immediate high risk. Subsequent evaluation is…
View more
Author(s):
Jeffrey Tabas
Added:
3 years ago
Approximately five million people present to the emergency department (ED) each year with chest pain, and billions of dollars are spent on assessment and treatment. Many therapies are time-dependent, so rapid identification of patients with acute coronary syndrome (ACS) - unstable angina (UA) and acute myocardial infarction (MI) - at high risk for adverse outcomes is essential. Missed or…
View more
Author(s):
Jeffrey Tabas
Added:
3 years ago
Approximately five million people present to the emergency department (ED) each year with chest pain, and billions of dollars are spent on assessment and treatment. Many therapies are time-dependent, so rapid identification of patients with acute coronary syndrome (ACS) - unstable angina (UA) and acute myocardial infarction (MI) - at high risk for adverse outcomes is essential. Missed or…
View more
Author(s):
Alan S Maisel
Added:
3 years ago
Acute coronary syndrome (ACS) and congestive heart failure (CHF) are significant health risks affecting a large part of the population. In both diseases, early detection and initiation of treatment significantly reduce the risk of serious adverse events and death. B-type natriuretic peptide (BNP) and myeloperoxidase (MPO) have both shown considerable utility in the early diagnosis of patients…
View more
Author(s):
Ajitha Kulasekaran
,
Lorna Swan
Added:
10 months ago
AHA 23: The ORFAN Study
Author(s):
Charalambos Antoniades
Added:
3 months ago
Video
Author(s):
Derek V Exner
Added:
3 years ago
Why Do We Need Risk Stratification Tools?
Sudden death accounts for between 300,000 and 500,000 deaths each year in North America.1 Patients with a history of myocardial infarction (MI) have a four-fold higher risk of sudden death than those without such a history. Most sudden deaths in ambulatory populations result from life-threatening ventricular arrhythmias that lead to a cardiac arrest.2…
View more
Author(s):
Gavin L Noble
,
Gary V Heller
Added:
3 years ago
Introduction
Coronary artery disease (CAD) is the leading cause of death in the US in both men and women, and in all ethnic groups that have been evaluated.1 The American College of Cardiology estimated the 1998 annual costs (direct and indirect) of CAD in the US to be US$368.4 billion, compared with cumulative cancer costs of US$189 billion.2 The scope of this problem is expanding as the…
View more
Author(s):
Gavin L Noble
,
Gary V Heller
Added:
3 years ago
Coronary artery disease (CAD) is the leading cause of death in the US in both men and women, and in all ethnic groups that have been evaluated. The American College of Cardiology estimated the 1998 annual costs (direct and indirect) of CAD in the US to be US$368.4 billion, compared with cumulative cancer costs of US$189 billion. The national focus on cardiovascular research, diagnosis and…
View more